Viewing nowCombinationX1-Al Tablet 5/160/10 mg
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.

MFDS item code 201902302 · Approved 2019.04.15 · Insurance code 640007380
Treatment of hypertension, improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used for patients who need to take a combination of amlodipine and valsartan and also rosuvastatin. The amlodipine/valsartan combination is effective in controlling blood pressure in patients with essential hypertension who have difficulty managing their blood pressure with existing monotherapy. Rosuvastatin is used to improve hypercholesterolemia and dyslipidemia and serves as an adjunct therapy when diet alone is not sufficient. Additionally, rosuvastatin helps slow the progression of atherosclerosis and reduces the risk of stroke, myocardial infarction, and revascularization procedures in patients at high risk for cardiovascular disease. In summary, this medication is used to manage blood pressure and cholesterol levels, improving cardiovascular health.
Take 1 tablet once daily with water. If possible, it is recommended to take it at the same time each day (e.g., before breakfast). This medication is intended for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and rosuvastatin. Patients taking an amlodipine/valsartan combination and rosuvastatin as separate medications may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before treatment with the amlodipine/valsartan combination, it is recommended that the dose of each individual ingredient (amlodipine or valsartan) be adjusted. However, if blood pressure is not adequately controlled with monotherapy using either ingredient, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients receiving dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80 mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose. ▷ Rosuvastatin 1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg once daily. 2. Older adults: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to this medication is increased in Asian patients, the recommended starting dose is 5 mg. The 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 mg. The 40 mg dose of rosuvastatin is contraindicated in some of these patients.
This medication may cause serious harm to the fetus when taken during the second and third trimester of pregnancy, so if pregnancy is confirmed, it should be discontinued immediately. Individuals who are allergic to this medication or similar ingredients, women who are pregnant or breastfeeding, or those with severe liver or kidney disease should not take this medication. Patients with low sodium or fluid levels may experience hypotension, so their condition should be carefully monitored before and during treatment, and blood pressure fluctuations should be closely observed. Patients with high potassium levels or those taking medications that can increase potassium should have their serum potassium levels frequently tested. Patients with impaired renal function or those who have had a kidney transplant should use this medication cautiously, and if symptoms of angioedema occur, they should discontinue use immediately. Patients with heart failure or those recovering from myocardial infarction should closely monitor their kidney function and symptoms while taking this medication. Elderly patients may respond more sensitively to this medication, so it is recommended to start with a lower dose and gradually adjust the dosage. Care should be taken when driving or operating machinery, as dizziness or fatigue may occur. Regular check-ups for liver function and muscle-related symptoms are important while taking this medication. If muscle pain, muscle weakness, or any unusual symptoms occur, consult a doctor immediately, and discontinue medication if necessary. Interactions with other medications may occur, so inform your doctor or pharmacist if you are taking other medications. Women who are pregnant or breastfeeding should not take this medication, and appropriate contraceptive measures should be taken if planning to become pregnant. Safety and effectiveness in children or teenagers under 18 years have not been established, so it is not recommended. Overdosage may result in severe hypotension, shock, heart problems, etc., so it is important to adhere to the prescribed dosage and visit a hospital immediately in case of overdose.
Peripheral edema, warmth, increased ALT, increased AST, increased serum creatinine, flank pain, neck pain, dizziness, sensory decrease, nasopharyngitis, rash, nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, drowsiness, orthostatic dizziness, sensory abnormalities, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, throat and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, erythema, hyperhidrosis, rash, pruritus, joint edema, back pain, arthritis, muscle cramps, lethargy, polyuria, nocturia, erectile dysfunction, edema, facial swelling, fatigue, flushing, asthenia, facial flushing, chest pain, pain, enuresis, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, hypercholesterolemia, hypoglycemia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, taste disturbance, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorder, enuresis, gynecomastia, pain, malaise, weight loss, weight gain, decreased hemoglobin, decreased hematocrit, neutropenia, serum sickness, increased serum potassium, vasculitis, bullous dermatitis, myalgia, renal failure, kidney injury, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, polyneuropathy, amnesia, peripheral neuropathy, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, eosinophilia, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive decline, forgetfulness, amnestic syndrome, memory impairment, confusion, severe muscle weakness, ocular muscle weakness, urticaria, pruritus, myopathy, rhabdomyolysis, weakness, arthralgia, fatigue, numbness, sensory abnormalities, chest discomfort, anorexia, abdominal distension, abnormal liver function tests, syncope, systemic pain, muscle cramps, gout
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and humidity. Additionally, it is recommended to store the medication at room temperature between 1°C and 30°C, avoiding extremes of temperature.
Pale orange, oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Valsartan 80mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharm Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.